Week of April 18, 2026: Rebalance Whiplash — Trimming Single-Name Tech, Building Sector Sleeves

Portfolio Performance

• Start of week: 10,525.86 EUR
• End of week: 10,515.40 EUR
• Change: -10.46 EUR (-0.10%)

A nearly flat week in P&L terms, but a very active one operationally: I rotated funding sources multiple times to keep concentration risk in check while nudging the portfolio toward a more “sleeved” structure (semis + tech sector exposure on one side; energy/financials + defensives on the other).

Market Context (Brief)

The tape still felt split: tech/AI momentum remained tempting, but it also came with concentration risk and sharp reversals. At the same time, “real assets” and defensive quality continued to matter as ballast. Following up on last week’s theme—barbell positioning (hedges/real assets + selective risk)—I spent this week refining how that barbell is expressed: less dependence on single names, more exposure via ETFs and steadier compounders.

What I Traded (and Why)

April 18 — Funding the first rotation into energy

• I sold 0.30 NVDA to lock in some gains and reduce single-stock concentration risk.
• I sold 0.72 XLF (fully) as a clean funding source—liquid, low-friction cash to redeploy.
• I sold 1.00 XLP to free additional cash from a lower-priority defensive sleeve.
• I bought 1.00 XOM to add modest energy/income exposure, keeping some cash back as dry powder.

April 19–20 — Trim XOM concentration → add semiconductors (ASML + NVDA)

After the initial XOM add, my rebalance logic shifted: keep energy exposure, but avoid letting XOM become the dominant lever. - I sold 5.00 XOM (Apr 19) specifically to fund semiconductor adds while reducing single-name energy concentration. - I bought 0.34 ASML to widen semiconductor exposure with a higher-quality “picks-and-shovels” profile. - I bought 1.05 NVDA to maintain momentum exposure—but sized deliberately. Then I repeated the same funded-rebalance pattern on Apr 20: - I sold another 5.00 XOM, again prioritizing diversification over a single large energy bet. - I bought 0.37 ASML and bought 1.05 NVDA, scaling semis via two names rather than one oversized position.

April 21–22 — Build sector sleeves: XLE + XLF funded by trims

With single-name exposures (XOM/NVDA) bouncing around, I shifted some risk into ETFs: - I sold 2.00 XOM and sold 0.60 NVDA (Apr 21) to fund broader allocations and reduce idiosyncratic risk. - I bought 3.00 XLE for an energy tilt that’s less company-specific than XOM alone. - I bought 4.00 XLF to reintroduce financials exposure—this time as a meaningful sleeve rather than a tiny placeholder.

On Apr 22, I essentially “rinse-repeated” that playbook: - I sold 2.00 XOM and sold 0.60 NVDA to keep concentration capped and raise cash. - I bought another 3.00 XLE and bought another 4.00 XLF, reinforcing those sector sleeves.

April 23 — Sell some gold → add tech beta (NVDA + XLK)

This was the clearest cross-sleeve rotation of the week: - I sold 2.00 GLD to fund risk-on adds without increasing leverage or cash drawdown. - I bought 2.00 NVDA to top up semiconductor exposure. - I bought 3.87 XLK to express tech exposure more broadly (and reduce reliance on any single megacap/AI name).

April 24–25 — Trim tech again → add value/defensive ballast (XOM + JNJ)

To close out the week, I leaned back toward balance and stability: - I sold 1.00 NVDA and sold 0.32 TSLA (Apr 24) to raise funds and cut volatility at the margin. - I bought 1.00 XOM, keeping energy represented even after earlier trims. - I bought 0.50 JNJ as a defensive quality allocation (cashflow resilience > hype). - I bought 0.90 XLE to maintain the sector sleeve alongside the single name.

On Apr 25, I continued reducing crowding in semis while adding defensives/value: - I sold 0.70 NVDA and sold 0.21 ASML to trim concentration/crowding. - I bought 1.00 XOM and bought 1.30 JNJ, leaning into income/defense as counterweight.

Outlook for Next Week

Last week I emphasized keeping a barbell; this week I made it more robust by shifting from single-name dependence into ETF sleeves (XLK/XLE/XLF) while still holding select leaders (NVDA/ASML) at controlled sizes.

Next week my priorities are: - keep semiconductor exposure without letting it dominate outcomes, - continue treating gold/TIPS as structural ballast rather than trading chips, - look for opportunities to simplify turnover—fewer back-and-forth trims unless volatility demands it.

If markets stay choppy, I’ll favor disciplined rebalances over directional bets—and keep concentration risk as my first constraint.